Hologic, Inc. (0J5Q.L)
USD 57.34
(0.03%)
USD 57.34
(0.03%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 970.2 Million USD | 45.15% |
| 2023 | 668.4 Million USD | -59.45% |
| 2022 | 1.64 Billion USD | -33.62% |
| 2021 | 2.48 Billion USD | 115.81% |
| 2020 | 1.15 Billion USD | 102.48% |
| 2019 | 568.2 Million USD | 11.85% |
| 2018 | 508 Million USD | 1.07% |
| 2017 | 502.6 Million USD | -10.11% |
| 2016 | 559.1 Million USD | 15.61% |
| 2015 | 483.6 Million USD | 32.46% |
| 2014 | 365.1 Million USD | 9.67% |
| 2013 | 332.9 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 226.7 Million USD | 20.07% |
| 2024 Q2 | 243.3 Million USD | 7.32% |
| 2024 Q3 | 244 Million USD | 0.29% |
| 2024 Q4 | 236.3 Million USD | -3.16% |
| 2023 FY | 941 Million USD | -42.91% |
| 2023 Q2 | 261.5 Million USD | -0.76% |
| 2023 Q1 | 263.5 Million USD | 47.7% |
| 2023 Q4 | 188.8 Million USD | -16.94% |
| 2023 Q3 | 227.3 Million USD | -13.08% |
| 2022 Q1 | 637.4 Million USD | 43.04% |
| 2022 FY | 1.64 Billion USD | -33.62% |
| 2022 Q4 | 178.4 Million USD | -22.2% |
| 2022 Q3 | 229.3 Million USD | -61.39% |
| 2022 Q2 | 593.9 Million USD | -6.82% |
| 2021 FY | 2.48 Billion USD | 115.81% |
| 2021 Q3 | 362.2 Million USD | -53.78% |
| 2021 Q4 | 445.6 Million USD | 23.03% |
| 2021 Q1 | 891.5 Million USD | 37.15% |
| 2021 Q2 | 783.7 Million USD | -12.09% |
| 2020 Q3 | 192 Million USD | 20.91% |
| 2020 Q4 | 650 Million USD | 238.54% |
| 2020 FY | 1.15 Billion USD | 102.48% |
| 2020 Q1 | 156.8 Million USD | -3.69% |
| 2020 Q2 | 158.8 Million USD | 1.28% |
| 2019 FY | 568.2 Million USD | 11.85% |
| 2019 Q4 | 162.8 Million USD | 10.0% |
| 2019 Q3 | 148 Million USD | 11.53% |
| 2019 Q1 | 144 Million USD | 4.58% |
| 2019 Q2 | 132.69 Million USD | -7.85% |
| 2018 Q2 | 129.3 Million USD | -6.24% |
| 2018 Q3 | 138.9 Million USD | 7.42% |
| 2018 Q4 | 137.7 Million USD | -0.86% |
| 2018 FY | 508 Million USD | 1.07% |
| 2018 Q1 | 137.9 Million USD | -9.46% |
| 2017 Q2 | 123.5 Million USD | -17.23% |
| 2017 FY | 502.6 Million USD | -10.11% |
| 2017 Q3 | 140.6 Million USD | 13.85% |
| 2017 Q1 | 149.2 Million USD | -0.53% |
| 2017 Q4 | 152.3 Million USD | 8.32% |
| 2016 Q4 | 150 Million USD | 1.97% |
| 2016 Q1 | 134.4 Million USD | 1.59% |
| 2016 Q2 | 139.9 Million USD | 4.09% |
| 2016 Q3 | 147.1 Million USD | 5.15% |
| 2016 FY | 559.1 Million USD | 15.61% |
| 2015 Q4 | 132.3 Million USD | 3.44% |
| 2015 FY | 483.6 Million USD | 32.46% |
| 2015 Q2 | 111.8 Million USD | 0.27% |
| 2015 Q1 | 111.5 Million USD | -0.62% |
| 2015 Q3 | 127.9 Million USD | 14.4% |
| 2014 Q1 | 79.6 Million USD | -9.44% |
| 2014 FY | 365.1 Million USD | 9.67% |
| 2014 Q3 | 82.9 Million USD | -6.75% |
| 2014 Q2 | 88.9 Million USD | 11.68% |
| 2014 Q4 | 112.2 Million USD | 35.34% |
| 2013 Q1 | 82.68 Million USD | 0.0% |
| 2013 Q4 | 87.9 Million USD | -4.04% |
| 2013 Q3 | 91.6 Million USD | 29.58% |
| 2013 Q2 | 70.69 Million USD | -14.5% |
| 2013 FY | 332.9 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | 836.266% |
| Accuray Incorporated | 504 Thousand USD | -192400.0% |
| Align Technology, Inc. | 643.33 Million USD | -50.807% |
| Elevance Health Inc. | 133.96 Billion USD | 99.276% |
| AxoGen, Inc. | -21.46 Million USD | 4620.548% |
| Boston Scientific Corporation | 2.34 Billion USD | 58.592% |
| CVS Health Corporation | 13.74 Billion USD | 92.94% |
| Cardinal Health, Inc. | 1.24 Billion USD | 21.947% |
| Centene Corporation | 2.93 Billion USD | 66.887% |
| DaVita Inc. | 1.6 Billion USD | 39.468% |
| HCA Healthcare, Inc. | 9.62 Billion USD | 89.922% |
| Humana Inc. | 4.01 Billion USD | 75.824% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 11.569% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | -33.71% |
| Masimo Corporation | 136.5 Million USD | -610.769% |
| McKesson Corporation | 3.9 Billion USD | 75.18% |
| Patterson Companies, Inc. | 252.92 Million USD | -283.593% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | 23.122% |
| ResMed Inc. | 1.31 Billion USD | 26.494% |
| Henry Schein, Inc. | 615 Million USD | -57.756% |
| Teladoc Health, Inc. | -248.55 Million USD | 490.339% |
| Universal Health Services, Inc. | 1.17 Billion USD | 17.457% |
| Veeva Systems Inc. | 429.33 Million USD | -125.978% |
| Baxter International Inc. | 390 Million USD | -148.769% |
| Becton, Dickinson and Company | 2.11 Billion USD | 54.041% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 45.087% |
| Danaher Corporation | 5.38 Billion USD | 81.97% |
| Stryker Corporation | 3.88 Billion USD | 75.046% |
| Medtronic plc | 5.14 Billion USD | 81.139% |